Possible hazards of handling antineoplastic drugs
Ng, L.M.; Jaffe, N.
Pediatrics 46(4): 648-649
1970
ISSN/ISBN: 0031-4005 PMID: 5503703 Document Number: 25000
Document emailed within 1 workday
Related Documents
Neiger, R. 1996: Guidelines for the handling of antineoplastic drugs Schweizer Archiv für Tierheilkunde 138(8): 383-386Gallelli, J.F. 1982: Evaluating the potential hazard of handling antineoplastic drugs American Journal of Hospital Pharmacy 39(11): 1877
Valanis, B.; Shortridge, L. 1987: Self protective practices of nurses handling antineoplastic drugs Oncology Nursing Forum 14(3): 23-27
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Zimmerman, P.F.; Larsen, R.K.; Barkley, E.W.; Gallelli, J.F. 1981: Recommendations for the safe handling of injectable antineoplastic drug products American Journal of Hospital Pharmacy 38(11): 1693-1695
Pesce, M. 1999: The handling of antineoplastic agents and Dlgs 626/94. Decreto legislativo (legislative decree) Minerva Medica 90(7-8): 271-278
Euller-Ziegler, L.; Mousnier-Martinez, A.; Michelon, F.; Carmillet, F.; Milletre-Bernardin, M.; Ziegler, G. 1990: Risks related to the handling of antineoplastic agents. Precautions to be observed at rheumatology departments Revue du Rhumatisme et des Maladies Osteo-Articulaires 57(2): 123-130
Trissel, L.A.; Parks, N.P.; Santiago, N.M. 1991: Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection American Journal of Hospital Pharmacy 48(10): 2186-2189
Burton, S.M. 1988: Handling cytotoxic drugs Professional Nurse 3(12): 496-497
Fischer, P. 1971: Handling drugs with gold content Pharmazeutische Praxis 10: 233
Lewis, B.J. 1970: Prescribing and handling drugs in hospital Nursing Mirror and Midwives Journal 131(16): 24-27
Greco, F.A.; Hande, K.R. 1979: The clinical pharmacology and use of antineoplastic drugs Journal of the Tennessee Medical Association 72(1): 23-33
Williams, S.F.; Schilsky, R.L. 2000: Antineoplastic drugs administered during pregnancy Seminars in Oncology 27(6): 618-622
Williams, S.F.; Schilsky, R.L. 2000: Antineoplastic drugs administered during pregnancy Seminars in Oncology 27(6): 618-622
Kuduk-Jaworska, J. 1984: Platinum complexes as potential antineoplastic drugs Postepy Higieny i Medycyny Doswiadczalnej 38(3): 281-322
Nissen, N.I. 1972: Evaluation of the clinical effect of antineoplastic drugs Ugeskrift for Laeger 134(25): 1345-1346
Buja, L.M.; Ferrans, V.J. 1975: Myocardial injury produced by antineoplastic drugs Recent Advances in Studies on Cardiac Structure and Metabolism 6: 487-497
Szmigiero, L. 1988: Topoisomerase Ii as a cellular receptor of various antineoplastic drugs Postepy Biochemii 34(3): 147-152
Gallelli, J.F.; Mahar, H. 1986: Chemical destruction and disposal of antineoplastic drugs American Journal of Hospital Pharmacy 43(7): 1679
Zhao, Z.Z.; Huang, M.T. 1992: A study of vitamin inhibition on the mutagenicity of the antineoplastic drugs Zhonghua Yu Fang Yi Xue Za Zhi 26(5): 291-293